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Abstract
The U.S. Department of Veterans Affairs (VA)and the U.S. Food and Drug Administration (FDA) have partnered to create a 
common framework for highlighting “use-issues” that can affect the ability to safely and effectively use ever-changing medical 
devices as envisioned. By examining event reports and device histories across VA’s Veterans Health Administration (VHA) and 
FDA’s Medical Product Safety Network (MedSun), this initiative will strive to realize safer patient care through identification of 
causal factors associated with the top use-issues.  Communication of these issues and their causes creates opportunities to 
improve device design, use, and serviceability of established and new medical devices.
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1. Introduction
In the United States, legislation requires medical device users to report device-related deaths, serious injuries, and 
certain malfunctions to the manufacturer and to the Food and Drug Administration (FDA).  After the realization that 
these events were severely underreported, the FDA began Medical Product Safety Network (MedSun) in 2002 to 
work collaboratively with the clinical community to “identify, understand, and solve problems with the use of 
medical devices.” A report published in February, 2005, concluded that establishing a culture of reporting takes 
tremendous trust and data analysis resources, and that it had success in motivating facilities to report [1].  
The U.S. Department of Veterans Affairs (VA) has a unified mission to serve and honor the men and women that 
have served in the nation’s armed forces. The Veterans Health Administration (VHA) is the largest integrated health
care system in the U.S. and one of the largest integrated health care systems in the world, with over 1,700 sites of 
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care, including a network of more than 150 medical centers, across the country and beyond. Part of the commitment 
to the almost nine million Veterans VA serves is that they are not harmed by the care provided to them; thus, the 
National Center for Patient Safety (NCPS) was established in 1999 to lead and focus VA’s patient safety efforts.
This paper will describe the ‘Purchasing for Safety’ initiative in hopes that other hospital systems may benefit 
from what has started. This initiative involves a joint partnership between these two government agencies to 
advance the ability to learn from events, such as adverse incidents, close-calls, frustrations with how a specific 
medical technology works or doesn’t work, usability issues and other concerns relating to proper use.
2. U.S. Food And Drug Administration / Medsun
2.1. Methods
MedSun has three major objectives:
x Rapid identification and understanding of problems related to the use of medical devices
x Provide a virtual laboratory to understand device problems
x Provide actionable feedback to health care professionals
Human factors are of primary concern, since most medical devices involve some type of setting or use by a 
person.  Understanding the risks imposed by physical and mental differences in users compounds the problems 
associated with medical device use. Approximately 250 hospitals, nursing homes and home health facilities from 
around the U.S. participate in the online MedSun program, sharing actual and potential adverse events.  The FDA 
and MedSun organizations recognize that problem identification may lead to the prevention of serious injuries and 
death and commit resources to participate, including:
x Designation of at least two staff members, one from risk management and one from biomedical or clinical 
engineering as facility representatives.  Optionally, other staff from materials management, patient safety, and 
specific clinical areas may participate.
x Designated representatives must participate in training on the online system.
x In order to facilitate communication between the clinical community and the FDA, designated representatives 
must participate in surveys and special studies related to specific medical products.  
Facilities benefit from the customized feedback they receive as well as increasing awareness of the importance of 
adverse event reporting.  Participating facilities have access to MedSun resources to support their efforts [2].  
2.2. Results
MedSun has existed for over a decade and now has a monthly newsletter (see the April 2015 edition 
at http://www.fda.gov/downloads/MedicalDevices/Safety/MedSunMedicalProductSafetyNetwork/Newsletters/UCM
440813.pdf) including highlighted recalls and links to FDA/CDRH databases including the Medical Device Safety 
Website and Warning Letters.  While the link to the Human Factor site was not operational, one FDA site does 
include Human Factors information and resources (see http://www.fda.gov/ medicaldevices/deviceregulation 
andguidance/humanfactors/ucm124829.htm).  
A report from the Brookings Institute [3] indicates that reports generated by the MedSun program contain higher 
quality data, but that they usually do not relate to the riskiest medical devices (Class III).  Their recommended 
approach to increasing patient safety through device surveillance is for a multi-stakeholder public-private 
partnership with sufficient authority and funding to implement a National Medical Device Postmarket Surveillance 
System (MDS).  
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3. Veterans Health Administration / NCPS
3.1. Methods
The nationwide reduction and prevention of inadvertent harm to patients as a result of their care is the primary 
goal of the VA NCPS. The NCPS strategy for improving safe patient care centers upon instilling a systems-
approach, where individual clinicians and hospitals view themselves as part of a larger system of healthcare.  As 
such, NCPS works to ensure that any event that resulted in a potential or actual adverse outcome is investigated and 
thoroughly understood to allow the entire organization to learn from a single incident. The intent is to never 
experience the same adverse outcome twice. 
Due to NCPS’ systems-approach to problem solving, VHA has a common framework for capturing the details 
and identifying the root cause(s) as well as contributing factor(s) for patient safety incidents across the entire health 
care system. Every VHA Medical Center and Veterans Integrated Service Network (VISN) is staffed with a Patient 
Safety Manager (PSM) and Patient Safety Officer (PSO), respectively, which NCPS trains to utilize the tools of 
Root Cause Analysis (RCA) and Healthcare Failure Mode and Effects Analysis (HFMEA). VHA Medical Centers 
and VISNs also receive support from NCPS through a team of Program Managers and Analysts. As strong actions 
are identified to eliminate or contain a reported system vulnerability that could cause harm to a patient, NCPS has 
the authority to send out a Patient Safety Alert requiring all VHA facilities to take prescribed actions to minimize 
chances that harm could occur elsewhere in the organization.
When analyzing patient safety issues to identify root causes/contributing factors, one of the challenges that VA 
Medical Centers consistently report involve the methods used for purchasing medical devices. There are numerous 
obstacles associated with complex acquisition processes, which can have unintended consequences on patients. As a 
result of a medical device procurement process riddled by rules, overburdened with limitations, and led by those not 
proficient in technology assessment or patient safety, newly acquired medical devices often introduce new risks into 
a system. Medical Centers frequently purchase dissimilar devices, each requiring different maintenance and cleaning 
protocols, and with very different user interfaces necessitating various operating procedures. End-users are forced to 
try to ‘remember’ such nuances associated with each medical device, which presents a significant opportunity for 
human error.
3.1. Results
One such example of how purchasing can introduce the opportunity for error involved a multi-dose pen injector 
(i.e., insulin pen). These injectors were purchased with the idea that utilizing this product would result in more 
efficient and cost effective procedures. As a result, pens were used in an inpatient setting on more than one patient. 
Staff made sure to use a new needle in accordance with policy; however, a single pen was used on more than one 
patient, which is not the intended use of this product. The fact that this type of use-error could happen was not 
surprising; yet the reaction to the admission to this lapse in awareness was extreme.  The RCA helped to understand 
that multi-dose pen injectors were not designed for use in a hospital unit, but were intended for home care by a 
single patient. NCPS responded to this issue by focusing on the purchasing part of medical product and device use, 
to ensure this type of error doesn’t occur again. 
In an effort to improve communication and encourage open dialog associated with purchasing at Medical 
Centers, NCPS reached out to the facility PSMs and VISN PSOs across the organization. VHA PSMs and PSOs 
provided valuable feedback pertaining to factors that can negatively influence a successful Patient Safety Program. 
A major concern identified was employee turnover, especially where the incoming PSM/PSO might not promptly 
receive NCPS training where human factors and usability testing is presented and discussed. The training also 
includes strategies for framing patient safety concerns so appropriate people hear these crucial conversations and 
can address themeffectively. NCPS developed supplementary training in response to this feedback and aimed the 
curriculum at improving medical device procurement.
The result is a set of NCPS-created Health Care Human Factors Engineering (HFE) Curriculum Modules, 
‘Improving Patient Safety by Bringing HFE to the Field’. The modules were designed for use at the Medical 
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Centersto train staff participating on purchasing committees. Each Module provides the PSM a Work Document to 
articulate the ‘take home message’ and purpose of the training; a Chapter that captures human factors literature 
should the instructor care to really understand where the research currently stands; a Lecture for the instructor to 
use, with PowerPoint slides; and then an Activity, or a lab, used to apply the concepts. There is an Introduction 
Section, and the following Modules:
1. Health Care Human Factors
2. Health Care Ergonomics
3. Cognition and Mental Workload
4. Product Usability
5. Usability Testing
6. Proactive Risk Assessment
7. Root Cause Analysis
8. Teamwork and Leadership
9. Communication and Handoffs
10. Stress and Fatigue
11. Multitasking and Mitigating Interruption
12. Addressing the Problem
13. Strength of Action
To improve the overall medical device procurement processes used by hospitals, it is vital to ensure patient safety 
principles, such as the ones outlined in NCPS’ HFE Curriculum Modules, are considered during the acquisition to 
reduce introducing new risks to patients by proactively identifying any potential for future use-issues during the 
medical device(s)/technology evaluation prior to purchase.
4. Agency collaboration
The size and diversity of VA’s healthcare system as well as the ability to identify and communicate use-issues 
has led to a joint venture between VHA and the U.S. FDA.This collaboration consists of ongoing discussions to 
advance the ability to learn from events, such as adverse incidents, close-calls, frustrations with why and how a 
specific medical technology works or doesn’t work. By analyzing typical use-issues and device histories, employees 
involved with pre-purchase device evaluations can benefit from the historical use data. VHA and FDA are both
using a structured approach that will encourage the medical device industry to share the usability and limit testing, 
as well as failure mode analyses for a device. Summarized data on life support device use from VHA Medical 
Centers will augment the FDA’s MedSun reports. Due to the size of the VA health care system and the significance 
of veteran health care needs, it seems likely that the NCPS would increase the incidence of Class III device reports.  
The plan is to host an industry day with medical device manufacturers to make sure that they benefit from the 
vulnerabilities the user population from over 400 hospitals (between VHA and FDA) have uncovered, and see if 
together we can learn more about how to best use the complex life-saving devices in production, and perhaps inform 
the next generation design.  
VA has also established a Patient Safety Center of Inquiry to examine end-user performance with various devices 
on the market, and preliminary discussion on how VHA and FDA can ‘pull the market’ with recognition, similar to 
the EnergyStar™ and SmartWay™ government recognition systems, for vendor products that have shared their 
‘limit of use’ test data and incorporated design changes to ensure an elimination (or at least a control of) 
vulnerabilities for safe patient care.  Perhaps this partnership of government and industry can result in a common 
‘use-test’ that covers most operational challenges seen in practice, similar to a check-ride in aviation or a dyno-test 
for automotive product.  The hope is that health care as an industry moves beyond the requirement to follow the 
exact wording of the manufacturer’s instruction, relying on correct application by the person and clear and complete
instruction;  to designing robust products that prevent the user from using the product outside of the envisioned 
performance envelop.
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While this vision might sound ambitious, it seems to have already inspired some of the heath care industry. Thus 
far two manufacturers have changed product or device design based on use-issues that could have resulted in patient 
harm.  One firebreak product can now effectively stop an oxygen fire from proceeding through the tubing into the 
cylinder no matter which orientation the product was inserted; and one dispenser is undergoing testing and possible 
redesign to make their product even safer for use with mental health patients. Lastly, in ongoing discussions to 
identify the root cause of a tragic and catastrophic failure mode of a gamma camera, fellow engineers from industry 
have voiced appreciation of our constructive suggestions for ‘what might have gone wrong’, based on partnering 
and collaborating instead of defending and blaming.  No one wants to see a patient harmed.
5. Conclusions
In summary, the VA and FDA have embraced a multi-faceted and innovative approach, challenging ourselves to 
‘purchase for safety’.  This approach started with increasing awareness that use-issues and human factors are a 
critical conversation for purchase teams.  Ongoing data collection efforts will result in using large data to share 
trends that any single hospital might not detect.  VHA, along with FDA, is committed to a leadership role in 
informing medical device manufacturers on ‘what can go wrong’ in use.
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